ASGE Postgraduate Course at ACG 2022: Expanding the Scope of Fundamental and Advanced Endoscopy | October 2022-Points and Counter Points: All Barrett's Should be Ablated

Points and Counter Points: All Barrett's Should be Ablated

Video Transcription

Video Summary

In this video, Dr. Nicholas Shaheen, Chief of Gastroenterology and Professor of Medicine at the University of North Carolina, argues in favor of ablating all Barrett's esophagus. He presents data showing that ablating nondisplastic Barrett's is effective in decreasing the risk of esophageal adenocarcinoma. He also addresses concerns about the risks, costs, and efficacy of ablation compared to surveillance endoscopy. Dr. Shaheen concludes that ablating all Barrett's is a safe, affordable, and timely approach that is necessary given the higher cancer risk associated with nondisplastic Barrett's.

Asset Subtitle

Nicholas J. Shaheen, MD, MPH, FASGE, MACG

Keywords

Barrett's esophagus

ablation

esophageal adenocarcinoma

surveillance endoscopy

cancer risk